Thursday, July 9, 2026

pharma · Advanced Solid Tumor · RNAZ

Transcode Therapeutics

Transcode Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Princeton, USA HQ
93 Employees
Public company Type
RNAZ · NYSE Ticker
Company details
Status
Public
HQ
Princeton, USA
Employees
93
Programs
2
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Transcode Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Transcode Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →